Annexon Inc (ANNX)
4.96
+0.26
(+5.53%)
USD |
NASDAQ |
May 24, 16:00
4.97
+0.01
(+0.20%)
After-Hours: 20:00
Annexon Cash and Short Term Investments (Quarterly): 264.95M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 264.95M |
| December 31, 2023 | 259.72M |
| September 30, 2023 | 165.27M |
| June 30, 2023 | 192.94M |
| March 31, 2023 | 228.16M |
| December 31, 2022 | 242.66M |
| September 30, 2022 | 269.52M |
| June 30, 2022 | 177.59M |
| March 31, 2022 | 206.66M |
| Date | Value |
|---|---|
| December 31, 2021 | 242.72M |
| September 30, 2021 | 271.37M |
| June 30, 2021 | 302.39M |
| March 31, 2021 | 326.65M |
| December 31, 2020 | 351.21M |
| September 30, 2020 | 370.69M |
| June 30, 2020 | 124.76M |
| March 31, 2020 | 33.35M |
| December 31, 2019 | 43.93M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
33.35M
Minimum
Mar 2020
370.69M
Maximum
Sep 2020
226.36M
Average
242.69M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| P3 Health Partners Inc | 27.30M |
| Arrowhead Pharmaceuticals Inc | 523.11M |
| Insmed Inc | 595.73M |
| Heron Therapeutics Inc | 71.52M |
| Kintara Therapeutics Inc | 6.351M |